Oric Pharmaceuticals, Inc. (ORIC) Dividend History

Company News

• ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  ORIC Pharmaceuticals, Inc. announced the grant of 39,100 non-qualified stock options and 6,500 restricted stock units to three new non-executive employees. The grants were made as inducements to employment in accordance with Nasdaq rules.

  GlobeNewswire Inc.
• ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  ORIC Pharmaceuticals, a clinical-stage oncology company, announced that it granted stock options and restricted stock units to two new non-executive employees as inducement awards. The grants were made under the company's 2022 Inducement Equity Incentive Plan.

  GlobeNewswire Inc.
• Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

  The article discusses the promising developments in cancer research, including new therapies and innovative technologies, and highlights recent updates from several biotech companies working on cutting-edge cancer treatments.

  Benzinga

  Featured Companies: ADPT ELEV NEO ONCY
• ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  ORIC Pharmaceuticals, a clinical-stage oncology company, announced granting stock options and restricted stock units to a new non-executive employee as an inducement to employment. The grants were made under the company's 2022 Inducement Equity Incentive Plan.

  GlobeNewswire Inc.
• C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

  C4 Therapeutics, Inc. (C4T) has appointed Steve Hoerter, a veteran with over three decades of experience in oncology commercialization, to its Board of Directors. Hoerter's expertise in strategically advancing oncology programs is expected to guide C4T's plans to become a fully integrated biotechnology company.

  GlobeNewswire Inc.

  Featured Companies: AGIO CCCC